Journal of Pharmacy and Pharmacology · 1998 · 16 citations · 21 references
Life SciencesBiochemistryPharmacologyBiochemical PharmacologyInflammationPharmacodynamicsNeutrophil BiologyProtein AggregationConcentration-dependent BindingEnzyme ActivityEnzyme Activity RegulationMembrane Translocation MechanismsNeutrophil PhysiologyPhosphatidylinositol 3-Kinase PathwayProtein Aggregation InhibitionProtein Kinase C Signaling
The influence of the plant product magnolol on neutrophil aggregation has been investigated in the rat. Magnolol inhibited phorbol 12-myristate 13-acetate (PMA)-activated rat neutrophil aggregation in a concentration-dependent manner with an IC50 (concentration resulting in 50% inhibition) of 24.2 +/- 1.7 microM. Magnolol suppressed the enzyme activity of neutrophil cytosolic and rat brain protein kinase C (PKC) over the same range of concentrations at which it inhibited the aggregation. Magnolol did not affect PMA-induced cytosolic PKC-alpha and -delta membrane translocation or trypsin-treated rat-brain PKC activity, but attenuated [3H]phorbol 12,13-dibutyrate binding to neutrophil cytosolic PKC. These results suggest that the inhibition of PMA-induced rat neutrophil aggregation by magnolol is probably attributable, at least in part, to the direct suppression of PKC activity through blockade of the regulatory region of PKC.
21
Masatoshi Inoue, Akira Kishimoto, Yoshimi Takai et al. · Journal of Biological Chemistry · 1977 · 864 citations · Full text
Marina Wolfson, Linda C. McPhail, V N Nasrallah et al. · The Journal of Immunology · 1985 · 301 citations